News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention Caitlin E. Cox October 21, 2019
News Daily News Statins Started in Kids With FH Provide Benefits in Adulthood Yael L. Maxwell October 17, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Dramatic Swings in Household Income Linked to CVD Risk: ARIC Michael O'Riordan October 09, 2019
News Daily News Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population Todd Neale September 18, 2019
News Daily News Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors L.A. McKeown September 16, 2019
News Daily News Greater Exposure to Toxins on 9/11 Left Firefighters at Increased Long-term CVD Risk L.A. McKeown September 11, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date Yael L. Maxwell September 03, 2019
News Conference News ESC 2019 Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events Michael O'Riordan September 02, 2019
News Conference News ESC 2019 BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests Yael L. Maxwell September 02, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Daily News Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events L.A. McKeown August 30, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019